TY - JOUR T1 - Tuberculosis research questions identified through the WHO policy guideline development process JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.02407-2018 VL - 53 IS - 3 SP - 1802407 AU - Nebiat Gebreselassie AU - Dennis Falzon AU - Matteo Zignol AU - Tereza Kasaeva Y1 - 2019/03/01 UR - http://erj.ersjournals.com/content/53/3/1802407.abstract N2 - High-quality research evidence is critical for improving global health and health equity, and for achieving the World Health Organization (WHO)'s objective of the attainment of the highest possible level of health by all peoples [1]. This need is most apparent when responding to complex epidemics such as tuberculosis (TB). TB is the leading killer among diseases caused by an infectious agent worldwide, the leading killer of people with HIV infection and a leading cause of death from airborne anti-microbial resistant infections, taking heavy tolls on human lives, communities and health systems at large [2, 3].WHO guideline development groups identify research questions using systematic reviews, economic analyses and stakeholder consultations during policy guidance development to identify urgent research gaps in the policy/implementation interface http://ow.ly/lUUw30nQZRO ER -